KR101764729B1 - Method of manufacturing a fine dust detox drink composition and itself - Google Patents
Method of manufacturing a fine dust detox drink composition and itself Download PDFInfo
- Publication number
- KR101764729B1 KR101764729B1 KR1020150121904A KR20150121904A KR101764729B1 KR 101764729 B1 KR101764729 B1 KR 101764729B1 KR 1020150121904 A KR1020150121904 A KR 1020150121904A KR 20150121904 A KR20150121904 A KR 20150121904A KR 101764729 B1 KR101764729 B1 KR 101764729B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- raw material
- extract
- composition
- mixed raw
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 72
- 239000000428 dust Substances 0.000 title abstract description 41
- 238000004519 manufacturing process Methods 0.000 title abstract description 20
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 title description 2
- 239000002994 raw material Substances 0.000 claims abstract description 75
- 239000000284 extract Substances 0.000 claims abstract description 51
- 238000001914 filtration Methods 0.000 claims abstract description 28
- 238000002156 mixing Methods 0.000 claims abstract description 27
- 238000000605 extraction Methods 0.000 claims abstract description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 12
- 108010059892 Cellulase Proteins 0.000 claims abstract description 10
- 238000004806 packaging method and process Methods 0.000 claims abstract description 10
- 229940106157 cellulase Drugs 0.000 claims abstract description 9
- 238000000354 decomposition reaction Methods 0.000 claims abstract description 9
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 9
- 108010059820 Polygalacturonase Proteins 0.000 claims abstract description 8
- 240000006365 Vitis vinifera Species 0.000 claims abstract description 8
- 108010093305 exopolygalacturonase Proteins 0.000 claims abstract description 8
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 claims abstract description 8
- 240000001717 Vaccinium macrocarpon Species 0.000 claims abstract description 7
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims abstract description 7
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims abstract description 7
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 7
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 7
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 7
- 235000004634 cranberry Nutrition 0.000 claims abstract description 7
- 239000002245 particle Substances 0.000 claims abstract description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 6
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 6
- 239000011718 vitamin C Substances 0.000 claims abstract description 6
- 244000075850 Avena orientalis Species 0.000 claims abstract description 5
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 5
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 241000332371 Abutilon x hybridum Species 0.000 claims description 16
- 238000003809 water extraction Methods 0.000 claims description 13
- 238000001816 cooling Methods 0.000 claims description 12
- 241001247821 Ziziphus Species 0.000 claims description 11
- 229940087559 grape seed Drugs 0.000 claims description 9
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 7
- 244000273928 Zingiber officinale Species 0.000 claims description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 7
- 235000008397 ginger Nutrition 0.000 claims description 7
- 229940010454 licorice Drugs 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 6
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 6
- 235000017803 cinnamon Nutrition 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 240000007124 Brassica oleracea Species 0.000 claims description 4
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 4
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 4
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 4
- 239000012676 herbal extract Substances 0.000 claims description 4
- 241000220324 Pyrus Species 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 3
- 235000021017 pears Nutrition 0.000 claims description 3
- 239000011343 solid material Substances 0.000 claims description 3
- 241001092459 Rubus Species 0.000 claims description 2
- 235000017848 Rubus fruticosus Nutrition 0.000 claims description 2
- 241000219094 Vitaceae Species 0.000 claims description 2
- 235000021019 cranberries Nutrition 0.000 claims description 2
- 235000021021 grapes Nutrition 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 239000011593 sulfur Substances 0.000 claims 2
- 235000013361 beverage Nutrition 0.000 abstract description 41
- 230000000144 pharmacologic effect Effects 0.000 abstract description 16
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 6
- 239000003440 toxic substance Substances 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract description 5
- 231100000614 poison Toxicity 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 3
- 102000004190 Enzymes Human genes 0.000 description 24
- 108090000790 Enzymes Proteins 0.000 description 24
- 229940088598 enzyme Drugs 0.000 description 23
- 206010061218 Inflammation Diseases 0.000 description 19
- 244000269722 Thea sinensis Species 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 235000013616 tea Nutrition 0.000 description 16
- 238000001784 detoxification Methods 0.000 description 14
- 230000004054 inflammatory process Effects 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 102000004889 Interleukin-6 Human genes 0.000 description 9
- 108090001005 Interleukin-6 Proteins 0.000 description 9
- 230000009471 action Effects 0.000 description 9
- 229940100601 interleukin-6 Drugs 0.000 description 9
- 230000004913 activation Effects 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 230000002757 inflammatory effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 235000010208 anthocyanin Nutrition 0.000 description 6
- 239000004410 anthocyanin Substances 0.000 description 6
- 229930002877 anthocyanin Natural products 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical compound C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 102000004127 Cytokines Human genes 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 150000004636 anthocyanins Chemical class 0.000 description 5
- 235000001465 calcium Nutrition 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 208000023504 respiratory system disease Diseases 0.000 description 5
- 101000973778 Homo sapiens NAD(P)H dehydrogenase [quinone] 1 Proteins 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 102100022365 NAD(P)H dehydrogenase [quinone] 1 Human genes 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000002934 diuretic Substances 0.000 description 4
- 230000001882 diuretic effect Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 235000012055 fruits and vegetables Nutrition 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 201000005202 lung cancer Diseases 0.000 description 4
- 208000020816 lung neoplasm Diseases 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- 101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 description 3
- 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 235000006533 astragalus Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000004576 sand Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 231100000167 toxic agent Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- APTNOIWSCDBIAS-UHFFFAOYSA-N 5,10,11-trihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C1C(O)C(O)C(CO)(CO)C2CCC3(C)C4(C)CC(O)C5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C APTNOIWSCDBIAS-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 2
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 2
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 2
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- SVINQHQHARVZFF-UHFFFAOYSA-N Ginkgotoxin Chemical compound COCC1=C(CO)C=NC(C)=C1O SVINQHQHARVZFF-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 101000588302 Homo sapiens Nuclear factor erythroid 2-related factor 2 Proteins 0.000 description 2
- 102000043136 MAP kinase family Human genes 0.000 description 2
- 108091054455 MAP kinase family Proteins 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 102100031701 Nuclear factor erythroid 2-related factor 2 Human genes 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 108091023040 Transcription factor Proteins 0.000 description 2
- 102000040945 Transcription factor Human genes 0.000 description 2
- 240000000851 Vaccinium corymbosum Species 0.000 description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 244000291414 Vaccinium oxycoccus Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000000809 air pollutant Substances 0.000 description 2
- 231100001243 air pollutant Toxicity 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- -1 anthocyanin compounds Chemical class 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000021014 blueberries Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 239000006049 herbal material Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 235000014786 phosphorus Nutrition 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 235000020439 pomegranate syrup Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 208000019553 vascular disease Diseases 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- NQWVSMVXKMHKTF-JKSUJKDBSA-N (-)-Arctigenin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-JKSUJKDBSA-N 0.000 description 1
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- ZQJJEJDWFORDKH-UHFFFAOYSA-N 5-[(2,5-dioxo-1-phenylimidazolidin-4-yl)methylsulfanylmethylsulfanylmethyl]-3-phenylimidazolidine-2,4-dione Chemical compound O=C1N(C=2C=CC=CC=2)C(=O)NC1CSCSCC(C1=O)NC(=O)N1C1=CC=CC=C1 ZQJJEJDWFORDKH-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- UNHHWEHQUUGKEE-MLLLWRCASA-N Amurensin Chemical compound C1=C(O)C(C(C(O)=C(O2)C=3C=CC(O)=CC=3)=O)=C2C(CCC(C)(O)C)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UNHHWEHQUUGKEE-MLLLWRCASA-N 0.000 description 1
- HDQHRTXBXYQUNW-CABCVRRESA-N Amurensine Natural products O(C)c1c(O)cc2[C@H]3c4c(cc5OCOc5c4)C[C@H](N(C)C3)c2c1 HDQHRTXBXYQUNW-CABCVRRESA-N 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- YYGRXNOXOVZIKE-UHFFFAOYSA-N Arctigenin Natural products COC1CCC(CC2COC(=O)C2CC3CCC(O)C(C3)OC)CC1OC YYGRXNOXOVZIKE-UHFFFAOYSA-N 0.000 description 1
- 102000008056 Aryl Hydrocarbon Receptor Nuclear Translocator Human genes 0.000 description 1
- 108010049386 Aryl Hydrocarbon Receptor Nuclear Translocator Proteins 0.000 description 1
- 102000003984 Aryl Hydrocarbon Receptors Human genes 0.000 description 1
- 108090000448 Aryl Hydrocarbon Receptors Proteins 0.000 description 1
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
- 108030001720 Bontoxilysin Proteins 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000016607 Diphtheria Toxin Human genes 0.000 description 1
- 108010053187 Diphtheria Toxin Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- HFTWTHSIMCSLFQ-CMLLUXCUSA-N Glabric acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@](C)(C(O)=O)[C@H](O)C[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C HFTWTHSIMCSLFQ-CMLLUXCUSA-N 0.000 description 1
- HFTWTHSIMCSLFQ-UHFFFAOYSA-N Glabric acid Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)C(O)CC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C HFTWTHSIMCSLFQ-UHFFFAOYSA-N 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- OIFFJDGSLVHPCW-UHFFFAOYSA-N Guayarol Natural products COc1ccc(CC2C(Cc3ccc(O)c(O)c3)COC2=O)cc1OC OIFFJDGSLVHPCW-UHFFFAOYSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- NQWVSMVXKMHKTF-UHFFFAOYSA-N L-Arctigenin Natural products C1=C(OC)C(OC)=CC=C1CC1C(CC=2C=C(OC)C(O)=CC=2)C(=O)OC1 NQWVSMVXKMHKTF-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- YYDLFVZOIDOGSO-KKBFJBPOSA-N Lycoricidine Chemical compound C1=C2C3=C[C@H](O)[C@@H](O)[C@@H](O)[C@@H]3NC(=O)C2=CC2=C1OCO2 YYDLFVZOIDOGSO-KKBFJBPOSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000218213 Morus <angiosperm> Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- LZAZURSABQIKGB-UHFFFAOYSA-N Narciclasine Tetraacetat Natural products C1=C2C3=CC(O)C(O)C(O)C3NC(=O)C2=C(O)C2=C1OCO2 LZAZURSABQIKGB-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 206010058530 Peripheral nerve palsy Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000006751 Platycodon Nutrition 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920001991 Proanthocyanidin Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- VAKIESMDOCVMDV-HNNXBMFYSA-N Spinosine Chemical compound C1C2=CC(O)=C(O)C=C2C[C@@H]2N1CCC1=C2C=C(OC)C(OC)=C1 VAKIESMDOCVMDV-HNNXBMFYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 241001441724 Tetraodontidae Species 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- UNHHWEHQUUGKEE-UHFFFAOYSA-N amurensin Natural products C1=C(O)C(C(C(O)=C(O2)C=3C=CC(O)=CC=3)=O)=C2C(CCC(C)(O)C)=C1OC1OC(CO)C(O)C(O)C1O UNHHWEHQUUGKEE-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940111205 diastase Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- FJSOHLNMRNSYFR-OPDZODGYSA-N epimedoside C Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(C/C=C(\C)/C)c2OC(c3ccc(O)cc3)=C(O)C(=O)c2c(O)c1 FJSOHLNMRNSYFR-OPDZODGYSA-N 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000004578 fetal growth Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000020542 functional tea Nutrition 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229910000078 germane Inorganic materials 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- GBRZTUJCDFSIHM-UHFFFAOYSA-N licorisoflavan B Natural products C1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OCC1C1=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-UHFFFAOYSA-N 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- NWFYESYCEQICQP-UHFFFAOYSA-N methylmatairesinol Natural products C1=C(OC)C(OC)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(OC)=C1 NWFYESYCEQICQP-UHFFFAOYSA-N 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229930189914 platycodon Natural products 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000011506 response to oxidative stress Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/708—Vitamin C
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a method for producing a fine dust detoxifying beverage composition and a composition using the method,
10% by weight of bokbunja, 21% by weight of MBA grape, 5% by weight of jujube, 4% by weight of omija, 5% by weight of oats, 5% by weight of cranberry and 30% (S10); A mixed raw material crushing step (S20) of adding a mixed raw material to a crusher and adding 0.1% by weight of vitamin C based on the total weight of the mixed raw material obtained in the raw material mixing step (S10) and crushing the mixed raw material; The decomposed raw material is introduced into an extractor and an enzymatic decomposition extraction step of adding 0.05% by weight of a cellulase and 0.025% by weight of a pectinase based on the total weight of the mixed raw materials obtained in the raw material mixing step (S10) and decomposing and extracting at 60 ° C for 1 hour (S30); An extract filtration step (S40) of filtering the extract with a filter to obtain a composition having a particle size of 60 mesh or less; (S50) in which the composition is filled in a packaging container, sealed, and sterilized at 70 DEG C for 30 minutes to obtain a final composition, thereby maximizing the pharmacological efficacy of the active ingredient contained in each raw material, It is advantageous to provide a beverage and beverage composition for oriental and non-vegitable beverages, which is absorbed into the body through fine dusts and detoxified to accumulate toxic substances and exhibits immunity and anti-inflammatory function.
Description
The present invention relates to a method for producing a fine dust detoxifying beverage composition and a composition using the method. More particularly, the present invention relates to a composition for extracting active ingredients from natural herbal materials and fruit and vegetables as raw materials, Thereby preventing accumulation of harmful substances absorbed in the body due to air pollution and showing an anti-inflammatory function.
Recently, the environmental pollution problem, which is getting worse and worse, has become a serious social issue because it gradually pollutes the atmosphere and water quality, which are essential for human survival, and causes various diseases such as this.
Especially, Korea is located geographically in the Far East of the Asian continent, and the yellow dust and air pollutants pushed by westerly winds from the continent are flowing into the Korean peninsula through the western coast of Korea, which ultimately pollutes water resources and soil. It is the situation that is going crazy.
Dusts were originally called sand dust winds originating from desert widely distributed in mainland China and Mongolia. However, recently, dust particles in the air including various pollutants from China, which is undergoing rapid industrialization, It is a helpless situation because it is affecting.
Based on the annual data released by the World Health Organization, the concentration of fine dust in Seoul is estimated to be 50 ~ 70 ㎍ / M 3 , which is 2 ~ 3 times higher than the recommended standard It is 1.5 to 2 times higher than New York, LA, London and Paris, and is higher than Japan.
The sand dust contained in the dust is mainly sucked into the human body through the eyes or the nose and directly harms the human body. In addition, it affects the crops and livestock by being mixed with the rainwater during the rainfall. Especially, , It induces various respiratory diseases such as asthma and chronic obstructive pulmonary disease as well as induces various inflammation in the body parts exposed to the air such as skin and eyeball and further causes cerebral blood vessels such as stroke, Diseases, cardiovascular diseases, depression, fetal growth disorders, and the like. Therefore, urgent measures are required to be prepared.
Fine dust contains large amounts of air pollutants, especially heavy metals such as lead, mercury, cadmium, nickel, sulfurous acid gas, and nitrogen oxides, which accumulate in the body once they are absorbed and accumulate. And it is known to cause genetic diseases.
In recent years, there has been an attempt to minimize the damage caused by dust and fine dust by cleaning indoor air using an air cleaner product or wearing a mask for preventing dust and fine dust when going out. However, Is not provided.
On the other hand, the development of various foods and medicines having the function of suppressing or releasing harmful toxic substances contained in fine dusts already inhaled into the body, such as heavy metals, has been continuously carried out. For example, -0839217 and a process for producing the same are as follows.
(W / w) of lemon juice, 38 to 39% (w / w) of orange juice, 3.7 to 3.8% of sugar syrup in 12 to 15% (w / w) (w / w) of pomegranate syrup, 12.3 to 13% (w / w) of pomegranate syrup and 25 to 25.7% (w / w) of water.
The functional tea beverage for detoxifying heavy metals to which the conventional techniques as described above is applied is in the form of a beverage containing a mixture of a tea tea and a fruit juice, which is a kind of fermentation tea having pharmacological properties such as antioxidant and anti-inflammation.
It has been known that the mushroom tea has physiological activities such as antioxidation, anti-inflammation and anti-allergy through a large number of studies, but it is difficult to meet the popular taste due to its unique flavor, The preference is lower than that of green tea or tea.
In addition, although the above-mentioned prior art has mixed flavors by mixing various fruit juices in the above-mentioned prior arts, it has been found that the flavor of the tea beans can be improved by drying the tea leaves from the picking of the leaves, tearing the leaves, rubbing the tea leaves, Due to the extremely difficult manufacturing process, there is a difficulty in supplying and dispensing a comparatively expensive boa tea. When boa tea, which is commercially available in mass production, is used, the content of the effective ingredient is insignificant, It is difficult to find out.
Accordingly, the present invention has been made to solve the above-mentioned problems,
10% by weight of bokbunja, 21% by weight of MBA grape, 5% by weight of jujube, 4% by weight of omija, 5% by weight of oats, 5% by weight of cranberry and 30% (S10);
A mixed raw material crushing step (S20) of adding the mixed raw material to a crusher and adding 0.1% by weight of vitamin C based on the total weight of the mixed raw material obtained in the raw material mixing step (S10) and crushing the mixed raw material;
The pulverized raw material is put into an extractor, and 0.05% by weight of the cellulase and 0.025% by weight of pectinase are added based on the total weight of the mixed raw materials obtained in the raw material mixing step (S10), followed by enzymatic decomposition extraction Step S30;
An extract filtration step (S40) of filtering the extract with a filter to obtain a composition having a particle size of 60 mesh or less;
And a sterilizing and packaging step (S50) in which the composition is filled in a packaging container, sealed and sterilized at 70 DEG C for 30 minutes to obtain a final composition, and a composition according to the preparation method is formed It is an object of the present invention to provide a detoxifying beverage composition which can maximize the pharmacological properties of the active ingredients contained in each raw material and thereby induce the toxic substance detoxifying enzyme inhaled and accumulated in the body through yellow sand and fine dust, It is possible.
The present invention relates to a natural herbal medicine having various pharmacological properties such as prevention of respiratory diseases and detoxification of toxic substances, anti-inflammation, immunity enhancement, etc. in order to protect human body from various harmful substances contained in fine dusts inhaled through environmental respiration, An advantage of providing a health functional beverage composition having an effect of activating a body-detoxifying enzyme and inhibiting an inflammatory reaction that is involved in detoxification of harmful substances that cause various diseases by effectively extracting an effective ingredient by selecting materials and fruits and vegetables .
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a flow chart showing a manufacturing process according to an embodiment of a method for producing a fine dust detoxifying beverage composition of the present invention. FIG.
FIG. 2 is a flow chart showing a process for manufacturing a bellflower herb extract in an embodiment of the method for producing a fine dust detoxifying beverage composition of the present invention. FIG.
FIGS. 3 to 4 are graphs illustrating analysis results of detoxification enzyme activity according to Experimental Examples of the fine dust detoxifying beverage composition of the present invention. FIG.
5 to 7 are graphs showing the results of the anti-inflammatory activity analysis according to Experimental Example of the fine dust detoxifying beverage composition of the present invention.
Hereinafter, the method of preparing the fine dust detoxifying beverage composition and the composition of the method of the present invention will be described in more detail as follows.
FIG. 1 is a flow chart showing a manufacturing process according to an embodiment of the method for producing a fine dust detoxifying beverage composition of the present invention. FIG. 2 is a view for explaining the preparation of a fine dust detoxifying beverage composition of the present invention FIGS. 3 to 4 are graphs showing analysis results of the detoxifying enzyme activation ability according to the experimental examples of the fine dust detoxifying beverage composition of the present invention, FIGS. 5 to 7 are graphs showing the results of the experiments of the fine dust detoxifying beverage composition The results of analysis of inhibition of inflammation according to the examples will be described together as a graph.
The method for producing a fine dust detoxifying beverage composition to which the technique of the present invention is applied and the composition according to the manufacturing method can be effectively used for extracting effective ingredients with various natural herbal materials and fruits and vegetables having pharmacological properties such as detoxification, And to provide a beverage composition having remarkable functionality such as detoxification of harmful toxins and anti-inflammation by inducing the activation of the body-detoxifying enzyme and the inhibition of the inflammatory reaction.
To this end, the present invention relates to a method for producing a raw material mixture, comprising a raw material mixing step (S10) of mixing a brambly, an MBA grape, a jujube, an omija, an oodi, a cranberry and a boat and adding a bellflower herb extract to a mixing raw material; (B) adding 0.1% by weight based on the total weight of the mixed raw materials obtained in the raw material mixing step (S10), and crushing the mixed raw materials; and feeding the crushed raw materials to an extractor, (S30) in which 0.05% by weight of a cellulase and 0.025% by weight of pectinase are added based on the total weight of the mixed raw materials obtained, and the resultant is decomposed and extracted at 60 DEG C for 1 hour, and the extract is filtered using a filter, (S40) for obtaining a composition having a viscosity of 60mesh or less and a sterilization container for obtaining the final composition by filling the container in a packaging container, sealing the container at 70 DEG C for 30 minutes, It comprises the step (S50).
In the raw material mixing step (S10), a mixed raw material in a state in which each raw material is uniformly stirred at a predetermined ratio is obtained. 10% by weight of brambles, 21% by weight of MBA grapes, 5% by weight of jujubes, 4% by weight of omija, 5% by weight of odi, 5% by weight of cranberries, 30% by weight of pearls in order to maximize efficacy while minimizing destruction of effective ingredients of each raw material. Are mixed and mixed, and 20% by weight of the bellflower herb extract is added to obtain a mixed raw material.
This is according to the result of analyzing the raw materials through a plurality of pharmacological experiments and deducing the optimum combination and compounding ratio. The pharmacological properties and efficacy of each of the raw materials will be briefly described below.
Bokbunja is a fragrant, sweet and bitter fruit, rich in anthocyanin compounds and contains vitamins and various minerals. Representative pharmacological actions include anti-inflammation and antioxidant activity, and it strengthens kidney and liver function, and is effective for fever, perspiration, diuretic, detoxification, and strengthens sight and strengthens the body.
The MBA grape is Muscat Bailey A (MBA), a grape variety derived from the West, and is sometimes referred to as the grape grape in Korea. It is abundant in pulp, excellent in dewaterability, and strong in sweetness, and is known as a wine varietal. Like bokbunja, it is abundant in anthocyanin, contains a large amount of nutrients such as calcium, carbohydrates and vitamins, and is effective in antioxidation, anti-aging, and vision improvement. Resveratrol, a polyphenolic substance, Is reported to be.
Jujube has a sweet and sour taste, and the pulpy contains abundant sugar as well as citric acid and tartaric acid. The jujube seeds contain betuline, betulic acid, and fat, and are used as a medicinal product for nourishment, nervous stability, blood purification, anti-aging and diuretic in one room.
Omija has five flavors: sweet, sour, bitter, salty, and spicy. It contains citric acid, malic acid, citral, sizandrine, and high ginsin to strengthen the heart, reduce blood pressure, and strengthen the immune system. In particular, it strengthens the pulmonary function and promotes the metabolism of the liver, and is effective for respiratory diseases and hepatitis. It has no toxicity and has a beautiful color, so it is good to drink with tea or liquor.
Audi is planted with the fruit of mulberry trees and has a sour taste and a refreshing fragrance. The main ingredient contains glucose, fructose, citric acid, malic acid, tannin, pectin, vitamins, calcium, phosphorus and iron. The main pharmacological effects of diabetes, thirst, alcohol and toxin decomposition, nervous stability, hematopoiesis, insomnia, fatigue, dizziness, blood sugar and cholesterol lowering effects are effective.
Cranberry is one of the most popular fruits in the United States and Europe, with blueberries originating in North America. It is mainly consumed as juice, jam, and dry matter, and is used as a main raw material for functional health food in Korea. It is rich in anthocyanins and contains nutrients such as carbohydrates, potassium, calcium, and vitamins. Its pharmacological actions include antioxidation, anti-aging, vision improvement, cholesterol lowering, and cardio-strengthening. It is also effective in preventing bacteria from being implanted in the body and improving periodontal disease, gastric ulcer and liver function.
Pears contain more than 85% of the moisture contained in the pulp and contain carbohydrates, sugars, malic acid, tartaric acid, citric acid, and vitamins. It protects the lungs and suppresses coughing and is effective for bronchial diseases, and is effective for colds, asthma, defecation and diuretic action. In addition, anti-inflammatory and detoxifying action is effective in eliminating hangovers.
In addition to the addition of water to obtain a liquid beverage composition during the manufacturing process of the beverage composition of the present invention, the bellflower extract of the present invention can be applied to a variety of oriental herbs, fruits, vegetables and the like including bellflower having a remarkable effect on anti- Is added as a raw material to further elucidate the weakness. The concrete production process of the bellflower herb extract will be described later.
On the other hand, after mixing the raw materials having the above-mentioned weakness, the raw material crushing step (S20) is performed to a predetermined size using a crusher to facilitate the extraction process.
In the mixing raw material crushing step (S20), vitamin C is added together with the raw material before crushing in an amount of 0.1% by weight based on the total weight of the mixed raw materials obtained in the raw material mixing step (S10). Vitamin C, as well known, resists infections, heals wounds and restores tissue, especially antioxidative action to prevent damage to the cell, such as adding, so that the nutrients contained in the raw materials to balance .
In the enzymatic decomposition extraction step (S30), an extract is obtained through an enzymatic hydrolysis extraction method. That is, by adding a pectinase and a cellulase enzyme to the crushed mixed raw materials, the effective ingredients of the raw materials are effectively extracted.
The cellulase is an enzyme that hydrolyzes cellulose to produce cellobiose. Pectinase is an enzyme that hydrolyzes pectin, which is a carbohydrate polymer, and decomposes and softens cell walls and fibrils of plant cells.
Generally, herbivores produce cellulase in the body to digest enough fiber. However, since human can not produce cellulase directly in the body, the fiber can not be digested and is discharged or partially decomposed by E. coli.
Accordingly, in the enzymatic decomposition and extraction step (S30), it is necessary to effectively soften the fibers contained in the raw materials used in the present invention and to decompose and extract the solid and liquid extracts, 0.05% by weight of cellulase and 0.025% by weight of pectinase.
In addition, extracts are extracted for 1 hour at a relatively low temperature of 60 ° C to facilitate digestion and absorption during drinking, and inhibit the formation of insoluble sediments, thereby softening the texture.
In the extract filtration step (S40), the solid material contained in the extract extracted in the enzymatic decomposition extraction step (S30) is filtered and filtered using a 60 mesh filtrate to obtain a liquid having a concentration suitable for drinking.
In the sterilization and packaging step (S50), various harmful bacteria remaining after the preparation process of the composition are removed before the packaging of the composition, but the paste is pasteurized at 70 DEG C for 30 minutes to minimize the destruction of nutritional components.
Meanwhile, the process for manufacturing the first step of the first step of the first step of the raw material mixing step (S10) is as follows.
(S100) in which water is mixed with water at a weight ratio of 3:10 and extracted for 2 hours, and a step (S100) of extracting water from the raw water, which is a mixture of ginger, bellflower, grape seed, hwanggi, licorice, cinnamon, Chinese cabbage, A first cooling step (S200) of cooling the extract obtained at the first hot water extraction step (S100) at room temperature for 20 hours, and cooling the solid material using the filter material to obtain a powder having a particle size of 60 mesh or less A first secondary filtration step S300 for obtaining a primary extract and a second secondary hot water extraction step S400 for collecting the solid filtered in the primary filtration step S300, A second cooling step (S500) of cooling the extract obtained at the second hot water extraction step (S400) at room temperature for 20 hours; cooling the cooled extract using a filter to obtain 60mesh (S600) for obtaining a second extraction liquid having a concentration A mixture of a second tea extract obtained in the first extract and the second filtering step (S600) obtained in the filtering step (S300) comprises a mixing completion (S700) to complete the final bellflower herbal extract.
In the first primary hot water extraction step (S100), the raw materials are mixed at a predetermined ratio into an extraction vessel, followed by hot water extraction for 2 hours to obtain an extract. 20% by weight of ginger, 40% by weight of bellflower, 1% by weight of grape seed, 3% by weight of grape seed, 10% by weight of grape seed, 2% by weight of licorice, 20% by weight of cinnamon, 1% by weight of cabbage, 5% by weight of bank, and 8% by weight of jujube are mixed with water at a weight ratio of 3:10 and extracted.
This is in accordance with the results obtained by analyzing the raw materials through a plurality of pharmacological experiments and deducing optimum combination and blending ratio. The pharmacological characteristics and efficacy of each raw material including the bellflower are as follows.
Ginger has more than 85% moisture and contains a large amount of minerals. It has a unique flavor due to its gingerol ingredient, it has a powerful sterilizing action against various pathogenic bacteria and acts as a pharmacological effect on heart strengthening, blood circulation promotion, chills, fever, headache and sputum. Diastase and proteolytic enzymes are also effective in promoting digestion and intestinal motility.
Platycodon is rich in carbohydrates, calcium, iron and fiber, and especially contains saponin and fliticone, which are the main components of ginseng, and acts as a pharmacological agent for antiinflammation, germane, antiulcer, shinhae, fever and analgesia. It is also used as a medicinal product because it has an effect of lowering blood sugar and cholesterol.
Grape seed is rich in antioxidant ingredients such as catechin and polyphenol to prevent aging, anti-inflammatory, anti-allergic and anti-viral functions to strengthen the immune system and lower cholesterol, which is also effective in vascular disease.
Hwanggi uses roots as medicines and contains polyacids, cholines, etc., and acts on the central nervous system as excitatory, tonic, and diuretic, and has a pharmacological action to inhibit nephritis, proteinuria, cholesterolemia, and lower blood pressure. It has also been used as a substitute for ginseng since it has efficacy for body weakness, fatigue bloating, spasmolithiasis, cold sweat, peripheral nerve palsy, edema, chronic nephritis.
Licorice is a medicinal herb that is used all over the world because it harmonizes the toxicity of all drugs and makes them appear more effective. It has the effect of strengthening blood circulation and musculoskeletal by regulating the intestines and fraud. It contains glycyrrhizin, glabric acid, sucrose, glucose, liquiritin, lycoricidine, etc. Glycyrrhizin has the effect of detoxifying diphtheria toxin, snake venom and blowfish poison. The main pharmacological action is detoxification, hepatitis, dermatitis, Jinhae, geomorphic, muscle relaxation, diuretic, anti-inflammation, acts and inhibits gastric and duodenal ulcers. Glycyrrhizin, a major component of licorice, inhibits enzymes metabolizing steroids, resulting in abnormal hormonal regulation when taken in large doses.
Cinnamon is rich in carbohydrates, minerals, and vitamins, warms the inside, keeps the blood vessels well, evenens the lungs and liver, and activates the nonfunctioning function. Therefore, it has effects on nourishment, sweating, fever, analgesia and fragility, and has a unique flavor.
Chinese cabbage is mainly used for soaking kimchi in Korea, and most of the water is rich in carbohydrates, vitamins, carotene, minerals such as calcium and phosphorus. Therefore, it is effective in fever, thirst, and digestion. Especially, it is known that the cinchinol component contained in the cabbage leaves is involved in the anticancer action.
The bank is called "白果 (白果)" in the oriental medicine, and it is used as a nourishing agent by acting as a ginger. It contains Jangsoo Platonic component to improve blood circulation, so it can prevent various vascular diseases, has an effect to regain energy, and is effective in preventing aging. Since it contains a toxic substance called 4-methoxypyridoxine (MPN), it is desirable not to consume more than the recommended amount.
The pharmacological action of jujube is omitted because it is similar to the above description.
Meanwhile, the extract extracted in the first hot water extraction step (S100) is naturally cooled at a room temperature through a first cooling step (S200).
The cooled extract is filtered through a first filtering step (S300) and filtered using a 60 mesh filtrate to form a liquid phase having a proper concentration, thereby obtaining a first extract.
The step of extracting the second hot water (S400) is a step of extracting the filtered solids again in the first filtering step (S300) so that the remaining effective ingredient can be extracted sufficiently.
The extract extracted in the second hot water extraction step (S400) is naturally cooled at a room temperature through a second cooling step (S500), and the remaining solid through a secondary filtration step (S600) is filtered using a 60 mesh filtrate Followed by filtration to obtain a second extract.
Finally, the first tea extract obtained in the first tea filtration step (S300) and the second tea extract obtained in the second tea filtration step (S600) are mixed through the mixing completion step (S700) And is used together with the other raw materials in the above-described raw material mixing step (S10).
As described above, there is an advantage that the extraction efficiency can be maximized while minimizing the destruction of the effective nutrients contained in the raw material by repeating the extraction process of the Drosophila orientalis extract twice.
Hereinafter, embodiments and experimental examples including the present invention having the above-described configuration will be described, and the effect of the embodiments will be grasped thoroughly.
≪ Example 1 >
Preparation of the extract of the herbal medicine of the present invention.
Ginger 60g, bellflower 120g, grape seed 3g, Hwanggi 9g, licorice 6g, cinnamon 60g, cabbage 3g, bank (bagasse) 15g, jujube 24g are prepared and mixed with 1ℓ of water and water is extracted for 2 hours.
The extract was cooled at room temperature for 20 hours and then filtered through a 60 mesh filtrate to separate the solid and obtain a first extract.
The solids were collected, mixed with 1 liter of water, mixed and extracted with hot water for 2 hours, cooled at room temperature for 20 hours, filtered through a 60 mesh filtration sieve, and the second extract was obtained.
The first tea extract and the second tea extract are mixed to complete an extract of Bellflower Herb Extract.
≪ Example 2 >
Preparation of the fine dust detoxifying beverage composition of the present invention.
200 g of bokbunjae, 420 g of MBA grape, 100 g of jujube, 80 g of omija, 100 g of oats, 100 g of cranberry and 600 g of pears were mixed and 400 g of the herb extract obtained in Example 1 was added to obtain a mixed raw material.
The mixed raw material is introduced into a crusher, and 0.1% by weight based on the total weight of the mixed raw materials obtained in the raw material mixing step (S10) is added to crush the vitamin C.
The crushed raw materials are added to the extractor, and the hydrolytic enzymes, such as cellulase and pectinase, are added in amounts of 0.05 wt% and 0.025 wt%, respectively, based on the total weight of the mixed raw materials obtained in the raw material mixing step (S10). Followed by decomposition and extraction at 60 ° C for 1 hour.
The extract was filtered through a 60 mesh filter to obtain a composition. The composition was sealed in a packaging container and sterilized at 70 ° C for 30 minutes to complete a fine dust detoxifying beverage composition.
Table 1 below shows the analysis of the active ingredients contained in the finished fine dust detoxifying beverage composition.
Hereinafter, Experimental Examples 1 to 2 for confirming detoxification enzyme activity and inflammation inhibiting ability of the fine dust detoxifying beverage composition of the present invention will be described.
The detoxifying enzyme activation ability is a detoxifying enzymatic action mechanism mainly occurring in the liver responsible for the detoxification of the body. It activates the phosphorylation enzyme including the mitogen-activated protein kinase (MAPK) in the cell due to the stimulation of the chemical component from the outside, Nrf2, which is a transcription factor, migrates into the nucleus and binds to the promoter gene, thereby detoxifying the toxic substance through the action of the expression and activation of the detoxifying enzyme protein.
Inhibition of inflammation is caused by activation of inflammatory signal pathway caused by external inflammatory factors, among which NFkappaB, which is a transcription factor, is transferred into the nucleus and binds to NFkappaB site to secrete inflammatory cytokine Therefore, NFkappaB signaling to inhibit the secretion of inflammatory cytokines or inhibit the secretion of selected ingredients to induce inflammation is induced.
<Experimental Example 1>
Analysis of Detoxification Enzyme Activation Ability of the Fine Dust Detox Beverage Composition of the Present Invention.
To confirm the detoxification effect, the activation of the two-phase detoxifying enzyme system was confirmed using the colorimetric method. Hepa1c1c7 cells, hepatocellular carcinoma cells of the experimental animals, were treated with the raw materials of the micro-dust detoxifying beverage composition of the present invention prepared in Examples 1 and 2, and NQO1 activation, a two-phase detoxifying enzyme indicator enzyme, was measured. As shown in the graphs shown in Figs. 3 to 4.
As a result, it was confirmed that tBHQ was used as a positive control and NQO1 enzyme activity, which is similar to or higher than that of the positive control group, was found in the raw material of beverage detergent composition of the present invention, and grape seed, The bloom extract showed a similar NQO1 enzyme activity, though slightly lower than the positive control group. In addition, NQO1 enzyme activity was lower in blueberry, raspberry, audi and garlic than in the positive control group, but the enzyme activity was stronger than the control group.
These results suggest that quercetin, terpenoids, anthocyanin, and the like contained in the raw material added to the fine dust detoxifying beverage composition of the present invention induce a two-phase detoxifying enzyme system, Was able to verify the enzymatic activity of the detoxification enzyme.
<Experimental Example 2>
Analysis of inflammation inhibition ability of the fine dust detoxifying beverage composition of the present invention.
(1) In order to confirm the inhibition of inflammation, lung cancer cells are used to evaluate the efficacy of IL-6 (interleukin 6), an inflammatory cytokine, in respiratory diseases.
First, lung cancer cells were cultured and IL-6 was identified using an conditioned medium after treating the fine dust detoxifying beverage composition of the present invention prepared in Examples 1 and 2, 5 as shown in the graph.
As a result, it was confirmed that the fine dust-detoxifying beverage composition slightly reduced IL-6 by treatment with LPS, which is an exogenous inflammation inducer.
(2) In order to confirm the change in the amount of inflammatory cytokine secretion in the microenvironment through co-culture of macrophages and lung cancer cells, which initiate the inflammatory reaction, THP-1 monocytes ) Was treated with TPA to differentiate into macrophages. Pretreatment of the micro-dust detoxifying beverage composition of the present invention into lung cancer cells, followed by co-culturing of the two cells, IL-6 secretion was assayed in the culture medium after treatment with LPS, And the results are as shown in the graph shown in FIG.
As a result, IL-6 was increased by 200 pg / ml when LPS was treated with the inflammation inducer, and IL-6 was remarkably decreased by pretreatment of the fine dust detoxifying beverage composition. Therefore, it was confirmed that the detoxifying beverage composition of the present invention alleviated lung inflammation.
(3) The efficacy evaluation test of the fine dust detoxifying beverage composition of the present invention was carried out in an experimental animal treated with benzoprene (benzo [a] byrene), which is a strong fine dust component.
Benzopyrene is a strong carcinogen with five benzene rings. It is absorbed into the lungs through the bronchial mucous layer after inhalation and irritates the skin. It is also transformed into the toxic metabolite, benzopyran 7,8-diol-9,10 epoxide, by the cytochrome P450 1A1,1A2,1B2, which is a 1-phase enzyme in the body.
The more specific toxic action and the mechanism to decode it are outlined below.
The benzopyran is bound to an aryl hydrocarbon receptor and the arylhydrocarbon is transferred into the nucleus by an arylhydrocarbon nuclear translocator and activates the cytochrome P450 promoting gene to activate the CYP450 protein and activate the enzyme Benzopyran is transformed into a more potent toxic component, causing oxidative stress and inflammatory responses.
Therefore, the experiment is conducted to activate the Nrf2 / 2 phase detoxifying enzyme action mechanism by the detoxification mechanism which can inhibit it.
Over the course of a total of 15 days, the fine dust detoxifying beverage composition of the present invention was orally administered to experimental animals at intervals of two days. On the 16th day, 1 mg of benzopyran was administered to each animal, sacrificed the next day to collect blood and tissues, and the blood was separated into plasma, and the secretion amount of IL-6, an inflammatory cytokine, was analyzed. As shown.
As a result, the amount of secreted IL-6, TNF alpha and IL-1beta in blood was increased in the group treated with benzopyran, and when the composition of the present invention was administered by concentration, It was confirmed that the secretion amount of cain was reduced.
Through the above-described Experimental Examples 1 to 2, it was verified that the fine dust-detoxifying beverage composition of the present invention exhibits detoxification enzyme activity and inflammation inhibitory activity in vivo and in vivo.
The method for producing a fine dust detoxifying beverage composition of the present invention having the above-described composition and the composition for the manufacturing method according to the present invention can be applied to a natural herbal medicine having a function capable of protecting the human body from various harmful substances generated by air pollution And the effective ingredient is effectively extracted by selecting materials and fruits and vegetables to prepare a fine dust-detoxifying beverage composition.
Accordingly, the present invention provides a health functional beverage composition having an excellent effect of detoxifying poisonous substances that are absorbed and accumulated in the body due to inhalation of yellow dust or fine dusts, causing various diseases, and preventing anti-inflammatory and respiratory diseases, and enhancing immunity There are various advantages of.
S10: raw material mixing step
S20: Mixing raw material crushing step
S30: Enzymatic decomposition extraction step
S40: Extraction filtration step
S50: Sterilization packaging step
S100: First hot water extraction step
S200: First cooling step
S300: First filtration step
S400: Second hot water extraction step
S500: Second cooling step
S600: Second filtration step
S700: Mixed completion stage
Claims (3)
A mixed raw material crushing step (S20) of adding the mixed raw material to a crusher and adding 0.1% by weight of vitamin C based on the total weight of the mixed raw material obtained in the raw material mixing step (S10) and crushing the mixed raw material;
The pulverized raw material is put into an extractor, and 0.05% by weight of the cellulase and 0.025% by weight of pectinase are added based on the total weight of the mixed raw materials obtained in the raw material mixing step (S10), followed by enzymatic decomposition extraction Step S30;
An extract filtration step (S40) of filtering the extract with a filter to obtain a composition having a particle size of 60 mesh or less;
And sterilizing and packaging the composition (S50) in which the composition is filled in a packaging container, sealed, and sterilized at 70 DEG C for 30 minutes to obtain a final composition.
The bellflower herbal extract solution may contain,
A raw material mixed with 20% by weight of ginger, 40% by weight of bellflower, 1% by weight of grape seed, 3% by weight of sulfur, 2% by weight of licorice, 20% by weight of cinnamon, 1% by weight of cabbage, 5% by weight of bank, A first hot water extraction step (S100) in which water is mixed at a weight ratio of 3:10 and extracted for 2 hours;
A first cooling step (S200) of allowing the extract obtained in the first hot water extraction step (S100) to be left at room temperature for 20 hours to cool;
A first primary filtration step (S300) of filtering the solid material by using the filtered extract to obtain a first extract having a particle size of 60 mesh or less;
A second hot water extraction step (S400) of collecting the solid filtered in the first filtering step (S300), mixing the resultant with 1 liter of water and extracting it for 2 hours;
A second cooling step (S500) of allowing the extract obtained in the second hot water extraction step (S400) to be left at room temperature for 20 hours to cool;
A second filtration step (S600) of filtering the cooled extract using a filter to obtain a second extract having a particle size of 60mesh or less;
And a mixing and finishing step (S700) of mixing the first extraction liquid obtained in the first filtration step (S300) and the second extraction liquid obtained in the second differential filtration step (S600) to complete the final Dorage herbal extract ≪ RTI ID = 0.0 > 1, < / RTI >
The bellflower extract solution contained 20% by weight of ginger, 40% by weight of bellflower, 1% by weight of grape seed, 3% by weight of sulfur, 2% by weight of licorice, 20% by weight of cinnamon, 1% Wherein the detergent composition is a detergent composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150121904A KR101764729B1 (en) | 2015-08-28 | 2015-08-28 | Method of manufacturing a fine dust detox drink composition and itself |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150121904A KR101764729B1 (en) | 2015-08-28 | 2015-08-28 | Method of manufacturing a fine dust detox drink composition and itself |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170025450A KR20170025450A (en) | 2017-03-08 |
KR101764729B1 true KR101764729B1 (en) | 2017-08-04 |
Family
ID=58403648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150121904A KR101764729B1 (en) | 2015-08-28 | 2015-08-28 | Method of manufacturing a fine dust detox drink composition and itself |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101764729B1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101898476B1 (en) * | 2017-12-28 | 2018-09-13 | (주)셀바이오랩 | Manufacturing method of drink using enzyme |
KR20190068812A (en) * | 2017-12-11 | 2019-06-19 | (주)셀바이오랩 | Manufacturing method of cabbage drink |
KR20190068818A (en) * | 2017-12-11 | 2019-06-19 | (주)셀바이오랩 | Manufacturing method of cabbage drink |
WO2020045688A1 (en) * | 2018-08-27 | 2020-03-05 | 농업회사법인우포의아침 주식회사 | Method for preparing enzymatically degraded, fruit and vegetable beverage |
KR102124855B1 (en) | 2020-02-13 | 2020-06-22 | 우영삼 | Vitamin Composition having Effect of Removing Fine Dust |
KR102169920B1 (en) | 2019-12-20 | 2020-10-26 | 문경시 | A composition comprising extract of Schisandra chinensis, pear and Platycodon grandiflorum for preventing or treating respiratory inflammatory diseases |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102260925B1 (en) | 2017-12-21 | 2021-06-04 | 한국과학기술연구원 | Composition for protecting cells and tissues against toxicity induced by particulate matter comprising lactobacillus casei |
KR102357737B1 (en) * | 2019-12-26 | 2022-02-03 | 홍익대학교 산학협력단 | Manufacturing method of mixed fruit tea comprising jujube and lime |
KR102357739B1 (en) * | 2019-12-26 | 2022-01-28 | 홍익대학교 산학협력단 | Manufacturing method of mixed fruit tea comprising jujube and Asian pear |
BG67521B1 (en) | 2020-06-22 | 2023-05-15 | „Ино Био Тех" ЕООД | Beverage formulation |
KR102596185B1 (en) * | 2020-12-28 | 2023-10-30 | 재단법인 임실치즈앤식품연구소 | Method for producing collagen jelly using Aralia continentalis mixed concentrate having anti-inflammatory activity for inflammation from microdust and antioxidant activity |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3832415B2 (en) | 2002-10-11 | 2006-10-11 | ソニー株式会社 | Active matrix display device |
KR100839217B1 (en) | 2006-12-19 | 2008-06-17 | 김태경 | Functional tea drink against heavy metal and manufacturing method thereof |
-
2015
- 2015-08-28 KR KR1020150121904A patent/KR101764729B1/en active IP Right Grant
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190068812A (en) * | 2017-12-11 | 2019-06-19 | (주)셀바이오랩 | Manufacturing method of cabbage drink |
KR20190068818A (en) * | 2017-12-11 | 2019-06-19 | (주)셀바이오랩 | Manufacturing method of cabbage drink |
KR102010464B1 (en) | 2017-12-11 | 2019-08-13 | (주)셀바이오랩 | Manufacturing method of cabbage drink |
KR102010446B1 (en) | 2017-12-11 | 2019-08-13 | (주)셀바이오랩 | Manufacturing method of cabbage drink |
KR101898476B1 (en) * | 2017-12-28 | 2018-09-13 | (주)셀바이오랩 | Manufacturing method of drink using enzyme |
WO2020045688A1 (en) * | 2018-08-27 | 2020-03-05 | 농업회사법인우포의아침 주식회사 | Method for preparing enzymatically degraded, fruit and vegetable beverage |
KR102169920B1 (en) | 2019-12-20 | 2020-10-26 | 문경시 | A composition comprising extract of Schisandra chinensis, pear and Platycodon grandiflorum for preventing or treating respiratory inflammatory diseases |
KR102124855B1 (en) | 2020-02-13 | 2020-06-22 | 우영삼 | Vitamin Composition having Effect of Removing Fine Dust |
Also Published As
Publication number | Publication date |
---|---|
KR20170025450A (en) | 2017-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101764729B1 (en) | Method of manufacturing a fine dust detox drink composition and itself | |
KR101738594B1 (en) | Prepatation method of black platycodon syrup and black platycodon syrup | |
CN102726580B (en) | Lucid ganoderma tea, lucid ganoderma teabag and processing technology thereof | |
CN103536793B (en) | Composition with functions of clearing away heat and toxic materials and removing fire as well as preparation method thereof | |
KR101615199B1 (en) | Functional compositions for relieving hangovers and protecting a liver, healthy food and food additive comprising the same | |
CN104312896A (en) | Compound fruit vinegar and preparing method thereof | |
CN102860549B (en) | Functional beverage having functions of beautifying and detoxification and preparation method thereof | |
CN105454963B (en) | The whole plant type beverage and preparation method thereof of no added table sugar and chemical addition agent | |
KR100894636B1 (en) | A manufacturing process of the beverage including yam extract | |
KR102011673B1 (en) | Hangover beverage composition | |
CN103767011A (en) | Plant beverage and preparation method thereof | |
KR100755728B1 (en) | Health food composition for asthma and preparation process of the same | |
CN109053849B (en) | Comprehensive utilization method of dogwood | |
CN101416722B (en) | Green bamboo health-care beverage and preparation method thereof | |
CN107384680B (en) | Passion fruit and longan fruit wine and brewing method thereof | |
CN108497246A (en) | A kind of plant weight losing function beverage and preparation method thereof | |
KR101409168B1 (en) | Method for manufacturing red ginseng extract with enhanced function and the extact thereof | |
KR20160063080A (en) | Method of Manufacturing Aronia Juice and Aronia Concentrate, and Aronia Juice and Aronia Concentrate Manufactured by the same Method | |
CN111557363B (en) | Oil-removed hawthorn lotus leaf tea beverage and preparation method thereof | |
CN113383834A (en) | A health black tea containing Curcuma rhizome and Glycyrrhrizae radix, and its preparation method | |
CN107028065A (en) | The method of carotenoid content and the preparation method of fermentation Chinese wolfberry fruit beverage in a kind of raising fructus lycii extracted solution | |
KR101950983B1 (en) | Composition of elderberry and mehod of making beverage using the same | |
KR20170125191A (en) | Pill using aronia berry and manufacturing method thereof | |
CN105816699A (en) | Sparassis crispa healthcare oral liquid with lipid and pressure reducing effects and preparation method thereof | |
KR100775639B1 (en) | Method of preparing doenjang, a korean soybean paste, containing extract of chrysanthemum indicum linne and the chrysanthemum doenjang obtained from the method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |